175 related articles for article (PubMed ID: 26725649)
21. Effect of lipid core material on characteristics of solid lipid nanoparticles designed for oral lymphatic delivery.
Paliwal R; Rai S; Vaidya B; Khatri K; Goyal AK; Mishra N; Mehta A; Vyas SP
Nanomedicine; 2009 Jun; 5(2):184-91. PubMed ID: 19095502
[TBL] [Abstract][Full Text] [Related]
22. Curcumin loaded solid lipid nanoparticles: an efficient formulation approach for cerebral ischemic reperfusion injury in rats.
Kakkar V; Muppu SK; Chopra K; Kaur IP
Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt A):339-45. PubMed ID: 23454202
[TBL] [Abstract][Full Text] [Related]
23. Lipid-based mucus penetrating nanoparticles and their biophysical interactions with pulmonary mucus layer.
Alp G; Aydogan N
Eur J Pharm Biopharm; 2020 Apr; 149():45-57. PubMed ID: 32014491
[TBL] [Abstract][Full Text] [Related]
24. Proof of concept studies to confirm the delivery of curcumin loaded solid lipid nanoparticles (C-SLNs) to brain.
Kakkar V; Mishra AK; Chuttani K; Kaur IP
Int J Pharm; 2013 May; 448(2):354-9. PubMed ID: 23558314
[TBL] [Abstract][Full Text] [Related]
25. Preparation, in vitro evaluation and statistical optimization of carvedilol-loaded solid lipid nanoparticles for lymphatic absorption via oral administration.
Shah MK; Madan P; Lin S
Pharm Dev Technol; 2014 Jun; 19(4):475-85. PubMed ID: 23697916
[TBL] [Abstract][Full Text] [Related]
26. A hybrid design to optimize preparation of lopinavir loaded solid lipid nanoparticles and comparative pharmacokinetic evaluation with marketed lopinavir/ritonavir coformulation.
Ravi PR; Vats R; Dalal V; Murthy AN
J Pharm Pharmacol; 2014 Jul; 66(7):912-26. PubMed ID: 24697749
[TBL] [Abstract][Full Text] [Related]
27. Highly water-soluble mast cell stabiliser-encapsulated solid lipid nanoparticles with enhanced oral bioavailability.
Patel RR; Chaurasia S; Khan G; Chaubey P; Kumar N; Mishra B
J Microencapsul; 2016 May; 33(3):209-20. PubMed ID: 26885889
[TBL] [Abstract][Full Text] [Related]
28. Improved oral delivery of resveratrol from N-trimethyl chitosan-g-palmitic acid surface-modified solid lipid nanoparticles.
Ramalingam P; Ko YT
Colloids Surf B Biointerfaces; 2016 Mar; 139():52-61. PubMed ID: 26700233
[TBL] [Abstract][Full Text] [Related]
29. Multivariate Optimization of Rizatriptan Benzoate-Loaded Solid Lipid Nanoparticles for Brain Targeting and Migraine Management.
Girotra P; Singh SK
AAPS PharmSciTech; 2017 Feb; 18(2):517-528. PubMed ID: 27126007
[TBL] [Abstract][Full Text] [Related]
30. Candesartan cilexetil loaded solid lipid nanoparticles for oral delivery: characterization, pharmacokinetic and pharmacodynamic evaluation.
Dudhipala N; Veerabrahma K
Drug Deliv; 2016; 23(2):395-404. PubMed ID: 24865287
[TBL] [Abstract][Full Text] [Related]
31. Cellular uptake and transcytosis of lipid-based nanoparticles across the intestinal barrier: Relevance for oral drug delivery.
Neves AR; Queiroz JF; Costa Lima SA; Figueiredo F; Fernandes R; Reis S
J Colloid Interface Sci; 2016 Feb; 463():258-65. PubMed ID: 26550783
[TBL] [Abstract][Full Text] [Related]
32. Lipid polymer hybrid as emerging tool in nanocarriers for oral drug delivery.
Hallan SS; Kaur P; Kaur V; Mishra N; Vaidya B
Artif Cells Nanomed Biotechnol; 2016; 44(1):334-49. PubMed ID: 25237838
[TBL] [Abstract][Full Text] [Related]
33. Histological assessment of follicular delivery of flutamide by solid lipid nanoparticles: potential tool for the treatment of androgenic alopecia.
Hamishehkar H; Ghanbarzadeh S; Sepehran S; Javadzadeh Y; Adib ZM; Kouhsoltani M
Drug Dev Ind Pharm; 2016; 42(6):846-53. PubMed ID: 26154267
[TBL] [Abstract][Full Text] [Related]
34. Absorption, pharmacokinetics and disposition properties of solid lipid nanoparticles (SLNs).
Wang J; Chen J; Ye N; Luo Z; Lai W; Cai X; Lin Y
Curr Drug Metab; 2012 May; 13(4):447-56. PubMed ID: 22443539
[TBL] [Abstract][Full Text] [Related]
35. Skin Transport of Hydrophilic Compound-Loaded PEGylated Lipid Nanocarriers: Comparative Study of Liposomes, Niosomes, and Solid Lipid Nanoparticles.
Rangsimawong W; Opanasopit P; Rojanarata T; Duangjit S; Ngawhirunpat T
Biol Pharm Bull; 2016; 39(8):1254-62. PubMed ID: 27476936
[TBL] [Abstract][Full Text] [Related]
36. Solid lipid nanoparticles for enhanced oral absorption: A review.
Salah E; Abouelfetouh MM; Pan Y; Chen D; Xie S
Colloids Surf B Biointerfaces; 2020 Dec; 196():111305. PubMed ID: 32795844
[TBL] [Abstract][Full Text] [Related]
37. In vivo fate of lipid-silybin conjugate nanoparticles: Implications on enhanced oral bioavailability.
Ma Y; He H; Xia F; Li Y; Lu Y; Chen D; Qi J; Lu Y; Zhang W; Wu W
Nanomedicine; 2017 Nov; 13(8):2643-2654. PubMed ID: 28778838
[TBL] [Abstract][Full Text] [Related]
38. Nanoemulsions (NEs), liposomes (LPs) and solid lipid nanoparticles (SLNs) for retinyl palmitate: effect on skin permeation.
Clares B; Calpena AC; Parra A; Abrego G; Alvarado H; Fangueiro JF; Souto EB
Int J Pharm; 2014 Oct; 473(1-2):591-8. PubMed ID: 25102113
[TBL] [Abstract][Full Text] [Related]
39. Comparison of the oral bioavailability of silymarin-loaded lipid nanoparticles with their artificial lipolysate counterparts: implications on the contribution of integral structure.
Shangguan M; Qi J; Lu Y; Wu W
Int J Pharm; 2015 Jul; 489(1-2):195-202. PubMed ID: 25956049
[TBL] [Abstract][Full Text] [Related]
40. Characterization and formulation optimization of solid lipid nanoparticles in vitamin K1 delivery.
Liu CH; Wu CT; Fang JY
Drug Dev Ind Pharm; 2010 Jul; 36(7):751-61. PubMed ID: 20136495
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]